Precision Medicine Programs Can Attain ROI Sooner Than Some Naysayers Maintain
Focusing on the right factors can accelerate a precision medicine program’s ROI…
Focusing on the right factors can accelerate a precision medicine program’s ROI…
As CMS announces readmission penalties for nearly 2,600 hospitals, some hospitals and health systems are finding precision medicine and big data efforts to be a new strategy for reducing 30-day readmissions…
Trends affecting hospitals and health systems worldwide are forcing them to alter how they are structured and how they deliver care. Here’s how precision medicine factors in…
Daryl Pritchard, PhD, discusses the untapped potential of multi-gene panel sequencing and targeted therapies for patients with advanced cancer….
Charis Eng, MD, PhD, explains how the Cleveland Clinic is overcoming workforce challenges in clinical cancer genetics…
Paul S. Appelbaum, MD, provides deeper insights into risks, privacy, and safeguarding patients’ genetic information…
Joshua C. Denny, MD, explains the importance of diverse genetic data in fueling precision-medicine breakthroughs…
Phil Febbo, MD, CMO of sequencing company Illumina, to discuss what company is doing to make it easier for health systems to adopt next-generation sequencing…
Mayo Clinic professor Richard Weinshilboum, MD, describes a near future in which preemptive gene sequencing becomes standard of care for safe and effective drug therapies…
It’s been a little more than a year since Geisinger launched its National Precision Health Initiative, a first-of-its kind unit designed to advance the promise of anticipatory medicine at Geisinger and at healthcare systems throughout the United States…